Back

PCSK9 inhibitors in clinical practice: expectations and reality

13 April 2019 (09:00 - 09:30)
Organised by:
Congress Presentation Part of: Management of dyslipidemia in the setting of cardiovascular prevention and rehabilitation Cardiovascular Rehabilitation EAPC Premium Access EuroPrevent 2019

About the speaker

Photo
Professor Zeljko Reiner

University Hospital Centre Zagreb, Zagreb (Croatia)

2 More presentations in this session

Presentation thumbnail
Familial hypercholesterolaemia is underdiagnosed and undertreated - Experience from Saudi Arabia
Doctor F. Alnouri (Riyadh, SA)
Slides Video
Presentation thumbnail
HDL-C, Triglycerides and Lp(a) - Role in the progression of coronary artery disease
Professor U. Landmesser (Berlin, DE)

Access the full session

Session thumbnail
Management of dyslipidemia in the setting of cardiovascular prevention and rehabilitation

The Event

Event poster

EuroPrevent 2019

13 April 2019 09:00 CET
You may be interested in
thumbnail
Congress Session
How to prescribe exercise for people with valvular heart disease or hypertension
thumbnail
Congress Session
Challenges in sports eligibility: what to do with…
thumbnail
ESC TV Today
Episode 15: Colchicine for secondary prevention - An algorithmic approach to the workup of syncope

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources